No Data
No Data
H.C. Wainwright Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Raises Target Price to $11
Express News | HC Wainwright & Co. Maintains Buy on Sensus Healthcare, Raises Price Target to $11
Express News | Revised - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More Than Doubling Versus 2023 Third Quarter
Press Release: REVISED - Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More Than Doubling Versus 2023 Third Quarter
Sensus Healthcare Analyst Ratings
Maxim Group Maintains Sensus Healthcare(SRTS.US) With Buy Rating, Raises Target Price to $14